In a randomized trial, low-dose oral minoxidil at 2.5 mg/d showed comparable hair density gains to 5 mg/d dosing in men with androgenetic alopecia (AGA), with fewer adverse events. Researchers ...
Eli Lilly says weight-loss drug Zepbound now available in 2.5- and 5-milligram vials at 50% discount
Eli Lilly & Co. LLY said Tuesday that patients can now access 2.5- and 5-milligram single-dose vials of its weight-loss treatment Zepbound with an on-label prescription at a discount of at least 50% ...
Orforglipron, a small-molecule, nonpeptide oral glucagon-like peptide-1 (GLP-1) receptor agonist, is being investigated as a treatment for obesity. In this phase 3, multinational, randomized, ...
Oral semaglutide at a dose of 25 mg may provide an alternative treatment option to injectable semaglutide (2.4 mg) and higher-dose oral semaglutide (50 mg) for persons with overweight or obesity. In a ...
An international trial reveals that a 7.2 mg dose of semaglutide drives greater weight loss than the standard 2.4 mg, but raises questions about side effect trade-offs in obesity treatment. Study: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results